Mark L. Schultz - Concepedia

Author

Mark L. Schultz

University of Michigan ORCID

Also Known As

M. Schultz, Mark L Schultz, Mark L. Schultz, Mark Schultz

Publications

740

Citations

H-Index

Concepts

All Affiliations

University of Michigan University of Iowa

About

Mark L. Schultz is an author at University of Michigan specializing in cell biology, medicine, and cellular physiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	118
2	Cell Biology	5	5	118
3	Cellular Physiology	3	3	65
4	Natural Sciences	2	2	54
5	Social Sciences	1	1	12

Mark L. Schultz

Publications

446

Citations

H-Index

Page 1

	Year	Citations
Coordinate regulation of mutant NPC1 degradation by selective ER autophagy and MARCH6-dependent ERAD Mark L. Schultz, Kelsey L. Krus, Susmita Kaushik, Nature Communications	2018	111
CLN3 Loss Disturbs Membrane Microdomain Properties and Protein Transport in Brain Endothelial Cells Luis Tecedor, Colleen S. Stein, Mark L. Schultz, Journal of Neuroscience	2013	66
Enhanced Toll-like receptor (TLR) responses of TNFR-associated factor 3 (TRAF3)-deficient B lymphocytes Ping Xie, Jayakumar Poovassery, Laura L. Stunz, Journal of Leukocyte Biology	2011	60
Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage Olga Ilnytska, Kimberly Lai, Kirill Gorshkov, Journal of Biological Chemistry	2021	50
Fbxo2 mediates clearance of damaged lysosomes and modifies neurodegeneration in the Niemann-Pick C brain Elaine A. Liu, Mark L. Schultz, Chisaki Mochida, JCI Insight MitophagyMolecular BiologyCell DeathLysosomal DamageCytoskeleton	2020	41
Modulating membrane fluidity corrects Batten disease phenotypes in vitro and in vivo Mark L. Schultz, Luis Tecedor, Shyam Ramachandran, Neurobiology of Disease ImmunologyGliomaCellular PhysiologyMembrane FluidityNeuroinflammation	2018	28
CLN3 Deficient Cells Display Defects in the ARF1-Cdc42 Pathway and Actin-Dependent Events Mark L. Schultz, Luis Tecedor, Colleen S. Stein, PLoS ONE Arf1-cdc42 PathwaySignal TransductionSignaling PathwayCell RegulationActin-dependent Events	2014	24
Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases Mark L. Schultz, Maria V. Fawaz, Ruth D. Azaria, BMC Medicine	2019	22
Measurement of oxygen production by in vitro human and animal lenses with an oxygen electrode Seymour Zigman, Joanne B. Schultz, Mark L. Schultz Current Eye Research	1998	19
Species-specific differences in NPC1 protein trafficking govern therapeutic response in Niemann-Pick type C disease Mark L. Schultz, Kylie J. Schache, Ruth D. Azaria, JCI Insight ImmunologyMolecular BiologyMutant Npc1Cellular PhysiologyGovern Therapeutic Response	2022	13

Page 1